Gyre Therapeutics (GYRE) Insider Trading & Ownership $9.21 -0.50 (-5.15%) Closing price 04:00 PM EasternExtended Trading$9.44 +0.23 (+2.50%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Gyre Therapeutics (NASDAQ:GYRE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.52%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$799,621.30 Get GYRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Gyre Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GYRE Insider Buying and Selling by Quarter Remove Ads Gyre Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/19/2025Songjiang MaPresidentSell2,000$10.13$20,260.00 3/17/2025Songjiang MaPresidentSell2,000$12.09$24,180.00 3/14/2025Songjiang MaPresidentSell2,000$12.31$24,620.00 3/12/2025Songjiang MaPresidentSell2,000$11.74$23,480.00 3/10/2025Songjiang MaPresidentSell2,000$10.14$20,280.00 3/7/2025Songjiang MaPresidentSell2,000$10.25$20,500.00 2/10/2025Songjiang MaPresidentSell2,000$11.90$23,800.00 2/4/2025Songjiang MaPresidentSell2,000$11.62$23,240.00 1/29/2025Songjiang MaPresidentSell2,000$11.43$22,860.00 1/27/2025Songjiang MaPresidentSell2,000$11.18$22,360.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/23/2025Songjiang MaPresidentSell2,000$10.49$20,980.00 1/21/2025Songjiang MaPresidentSell2,000$10.85$21,700.00 1/17/2025Songjiang MaPresidentSell2,000$10.72$21,440.00 1/15/2025Songjiang MaPresidentSell2,000$10.85$21,700.00 1/13/2025Songjiang MaPresidentSell56$10.10$565.60 1/10/2025Songjiang MaPresidentSell1,057$10.02$10,591.14 1/6/2025Songjiang MaPresidentSell941$10.16$9,560.56 1/2/2025Songjiang MaPresidentSell2,000$12.40$24,800.00 12/30/2024Songjiang MaPresidentSell2,000$12.50$25,000.00 12/26/2024Songjiang MaPresidentSell2,000$12.70$25,400.00 12/23/2024Songjiang MaPresidentSell2,000$12.27$24,540.00 12/19/2024Songjiang MaPresidentSell2,000$10.82$21,640.00 12/17/2024Songjiang MaPresidentSell2,000$11.05$22,100.00 6/28/2024Nassim UsmanDirectorSell3,452$12.00$41,424.00 5/1/2024Nassim UsmanDirectorSell20,000$14.13$282,600.00 (Data available from 1/1/2013 forward) GYRE Insider Trading Activity - Frequently Asked Questions Who is on Gyre Therapeutics's Insider Roster? The list of insiders at Gyre Therapeutics includes Nassim Usman, and Songjiang Ma. Learn more on insiders at GYRE. What percentage of Gyre Therapeutics stock is owned by insiders? 19.52% of Gyre Therapeutics stock is owned by insiders. Learn more on GYRE's insider holdings. Which Gyre Therapeutics insiders have been selling company stock? The following insiders have sold GYRE shares in the last 24 months: Nassim Usman ($324,024.00), and Songjiang Ma ($485,468.35). How much insider selling is happening at Gyre Therapeutics? Insiders have sold a total of 66,339 Gyre Therapeutics shares in the last 24 months for a total of $809,492.35 sold. Gyre Therapeutics Key ExecutivesDr. Han Ying Ph.D.CEO & DirectorMr. Songjiang MaPresident & Director23 recent tradesMs. Ruoyu Chen (Age 54)Interim Chief Financial Officer Mr. Weiguo YeChief Operating OfficerMs. Seline E. Miller CPA (Age 55)Senior Vice President of Finance More Insider Trading Tools from MarketBeat Related Companies PTCT Insider Ownership ADMA Insider Ownership ZLAB Insider Ownership RNA Insider Ownership OGN Insider Ownership ACLX Insider Ownership SWTX Insider Ownership RARE Insider Ownership AKRO Insider Ownership IMVT Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling This page (NASDAQ:GYRE) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GYRE Stock Free GYRE Stock Alerts